R

Rondo Therapeutics

11 employees

Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Biopharma
Life Science

Date founded

2021

Funding rounds raised

Total raised

$67M

from 3 investors over 3 rounds

R

Rondo Therapeutics raised $67M on March 2, 2022

Investors: Novo Holdings, SV Life Sciences and Red Tree Venture Capital

FAQ